본문 바로가기
KERD
논문KCI 등재

Adiponectin is Associated with Impaired Fasting Glucose in the Non-Diabetic Population

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

OBJECTIVES: Adiponectin is strongly associated with diabetes in the Western population. However, whether adiponectin is independently associated with impaired fasting glucose (IFG) in the non-obese population is unknown. METHODS: The serum adiponectin, insulin resistance (IR), and waist circumference (WC) of 27,549 healthy Koreans were measured. Individuals were then classified into tertile groups by gender. IFG was defined as a fasting serum glucose of 100-125 mg/dL without diabetes. IR was calculated using the homeostasis model assessment of insulin resistance (HOMA-IR). The association of adiponectin and IFG was determined using logistic regression analysis. RESULTS: WC and adiponectin were associated with IFG in both men and women. However, the association of WC with IFG was attenuated in both men and women after adjustment for the HOMA-IR. Adiponectin was still associated with IFG after adjustment for and stratification by HOMA-IR in men and women. Strong combined associations of IR and adiponectin with IFG were observed in men and women. Multivariate adjusted odds ratios (ORs) (95% confidence interval [CI]) among those in the highest tertile of IR and the lowest tertile of adiponectin were 9.8 (7.96 to 12.07) for men and 24.1 (13.86 to 41.94) for women. CONCLUSION: These results suggest that adiponectin is strongly associated with IFG, and point to adiponectin as an additional diagnostic biomarker of IFG in the non-diabetic population.

Abstract

OBJECTIVES: Adiponectin is strongly associated with diabetes in the Western population. However, whether adiponectin is independently associated with impaired fasting glucose (IFG) in the non-obese population is unknown. METHODS: The serum adiponectin, insulin resistance (IR), and waist circumference (WC) of 27,549 healthy Koreans were measured. Individuals were then classified into tertile groups by gender. IFG was defined as a fasting serum glucose of 100-125 mg/dL without diabetes. IR was calculated using the homeostasis model assessment of insulin resistance (HOMA-IR). The association of adiponectin and IFG was determined using logistic regression analysis. RESULTS: WC and adiponectin were associated with IFG in both men and women. However, the association of WC with IFG was attenuated in both men and women after adjustment for the HOMA-IR. Adiponectin was still associated with IFG after adjustment for and stratification by HOMA-IR in men and women. Strong combined associations of IR and adiponectin with IFG were observed in men and women. Multivariate adjusted odds ratios (ORs) (95% confidence interval [CI]) among those in the highest tertile of IR and the lowest tertile of adiponectin were 9.8 (7.96 to 12.07) for men and 24.1 (13.86 to 41.94) for women. CONCLUSION: These results suggest that adiponectin is strongly associated with IFG, and point to adiponectin as an additional diagnostic biomarker of IFG in the non-diabetic population.

참고문헌 (29)

  1. "Diabetes programme"[URL]
  2. The Asia-Pacific perspective: redefining obesity and its treatment, "Bassett J", Health Communications Australia, ~ (2000)
  3. Korea Centers for Disease Control and Prevention, "The Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV), 2008" (2009), Ministry for Health, Welfare and Family Affairs
  4. Wong MS, "The Singapore impaired glucose tolerance follow-up study: does the ticking clock go backward as well as forward", Diabetes Care, 26, pp.3024~303 (2003)
  5. 엄홍대, "규칙적 운동과 제 2형 당뇨병 발생에 관한 전향적 코호트 연구- 공복혈당장애군을 대상으로", 예방의학회지, 41(1), pp.45~50 (2008), 대한예방의학회
  6. Valensi P, "Pre-diabetes essential action: a European perspective", Diabetes Metab, 31, pp.606~620 (2005)
  7. Meigs JB, "Baltimore Longitudinal Study of Aging. The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging", Diabetes, 52, pp.1475~1484 (2003)
  8. Lecomte P, "Five-year predictive factors of type 2 diabetes in men with impaired fasting glucose", Diabetes Metab, 33, pp.140~147 (2007)
  9. Qian Y, "The characteristics of impaired fasting glucose associated with obesity and dyslipidaemia in a Chinese population", BMC Public Health, 10, pp.139~ (2010)
  10. Baena-Díez JM, "Waist circumference and impaired fasting glucose screening in a Mediterranean population", Diabetes Res Clin Pract, 86, pp.e12~e14 (2009)
  11. Chang SA, "Body mass index is the most important determining factor for the degree of insulin resistance in non-obese type 2 diabetic patients in Korea", Metabolism, 53, pp.142~146 (2004)
  12. 박이병, "우리나라 당뇨병의 역학적 특성 -대한당뇨병학회·건강보험심사평가원 공동연구 결과를 중심으로", Diabetes and Metabolism Journal, 33(5), pp.357~362 (2009), 대한당뇨병학회
  13. Yoon SJ, "The association between adiponectin and diabetes in the Korean population", Metabolism, 57, pp.853~857 (2008)
  14. Yun JE, "Serum adiponectin as a useful marker for metabolic syndrome in type 2 diabetic patients", Diabetes Metab Res Rev, 25, pp.259~265 (2009)
  15. Arita Y, "Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity", Biochem Biophys Res Commun, 257, pp.79~83 (1999)
  16. Weyer C, "Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia", J Clin Endocrinol Metab, 86, pp.1930~1935 (2001)
  17. Yamamoto Y, "Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population", Clin Sci (Lond), 103, pp.137~142 (2002)
  18. Jee SH, "Development of ELISA-kit of quantitative analysis for adiponectin and their correlation with cardiovascular risk factors", Korean J Epidemiol, 29, pp.165~175 (2007)
  19. Ruderman N, "The metabolically obese, normal-weight individual revisited", Diabetes, 47, pp.699~713 (1998)
  20. Hotta K, "Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys", Diabetes, 50, pp.1126~1133 (2001)
  21. Yamauchi T, "The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity", Nat Med, 7, pp.941~946 (2001)
  22. Nilsson PM, "Plasma adiponectin levels in relation to carotid intima media thickness and markers of insulin resistance", Arterioscler Thromb Vasc Biol, 26, pp.2758~2762 (2006)
  23. Duncan BB, "Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study", Diabetes, 53, pp.2473~2478 (2004)
  24. Greenfield JR, "Relationship between inflammation, insulin resistance and type 2 diabetes: ‘cause or effect’", Curr Diabetes Rev, 2, pp.195~211 (2006)
  25. Shand BI, "Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study", Int J Obes (Lond), 33, pp.1274~1279 (2009)
  26. Knobler H, "Adiponectin and the development of diabetes in patients with coronary artery disease and impaired fasting glucose", Eur J Endocrinol, 154, pp.87~92 (2006)
  27. Choi KM, "Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans", Clin Endocrinol (Oxf), 61, pp.75~80 (2004)
  28. Wang Z, "Are the associations of plasma leptin and adiponectin with type 2 diabetes independent of obesity in older Chinese adults", Diabetes Metab Res Rev, 26, pp.109~114 (2010)
  29. Snijder MB, "Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study", Diabetes Care, 29, pp.2498~2503 (2006)

관련 논문AI추천

이 간행물의 다른 논문 (10건)